Staining of the biopsy sample with HMB-45 antigen (a monoclonal antibody specific for melanocyte cells) or cytokeratin allows AML to be distinguished from RCC and oncocytoma [5]. This evidence concerns the gene PMEL and acute myeloid leukemia.